TCL Archive More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010. July 29, 2005
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita May 30, 1980
